Verzenio is available as a 50 mg, 100 mg, 150 mg, and 200 mg oral tablet with recommended dosing of 150 mg twice daily when given in combination with fulvestrant and 200 mg twice daily when given alone. The average wholesale price (AWP) per tablet is $234.60. NPS is planning to review Verzenio for placement on the national formularies. For additional details on Verzenio, please view the FDAâs press release.
TUESDAY, Oct. 20 (HealthDay News) -- New research raises doubts about the long-held medical dogma that dangerous blood clots in the lungs, known as pulmonary emboli, originate from clots in the deep veins of the legs or other parts of the lower body, which then break up and travel up through the body.
A pulmonary embolism may be serious and life threatening. Each year, more than 100,000 cases of pulmonary embolism occur in the United States (Source: NHLBI). Deep vein thrombosis is the primary cause of pulmonary embolism. In deep vein thrombosis, blood clots form in the large veins of the legs. A blood clot may break free in a leg vein and travel through the bloodstream to the lungs, where it can cause symptoms by blocking an artery. Search Now.